Background: Low rates of participation of adolescents and young adults (AYAs) in clinical oncology trials may contribute to poorer outcomes. Factors that influence the decision of AYAs to participate in health research and whether these factors are different from those that affect the participation of parents of children with cancer. Methods: This is a secondary analysis of data from validated questionnaires provided to adolescents (\u3e12 years old) diagnosed with cancer and parents of children with cancer at 3 sites in Canada (Halifax, Vancouver, and Montreal) and 2 in the United States (Atlanta, GA, and Memphis, TN). Respondents reported their own research participation and cited factors that would influence their own decision to partici...
Victoria Forcina,1 Branavan Vakeesan,1 Chelsea Paulo,1 Laura Mitchell,1 Jennifer AH Bell,2 Seline Ta...
Abstract Background Adolescent and young adults (AYA)...
PURPOSE OF THE RESEARCH: Despite decision-making featuring throughout the trajectory of cancer care,...
Background: Low rates of participation of adolescents and young adults (AYAs) in clinical oncology t...
To access publisher's full text version of this article click on the hyperlink at the bottom of the ...
Purpose Few studies have addressed the way in which families of children with cancer make treatment ...
Adolescents and young adults (AYAs) with cancer are encouraged or expected to be involved in treatme...
BACKGROUND: Various regulations and guidelines stipulate the importance of involving adolescents in ...
Purpose: Adolescents and young adults (AYAs) aged 15-39 at diagnosis have very low cancer clinical t...
PURPOSE: There is an increasing demand for researchers to provide research results to participants. ...
Background.Various regulations and guidelines stipulate the importance of involving adolescents in d...
PROBLEM IDENTIFICATION:Involvement in treatment decision making (TDM) is considered a key element of...
Despite overall improvement in survival, morbidity, and quality of life of US patients with cancer, ...
Survival among adolescents and young adults (AYAs) ages 15 to 39 with cancer has not improved to the...
Purpose: Although cancer clinical trials (CT) offer opportunities for novel treatments that may lead...
Victoria Forcina,1 Branavan Vakeesan,1 Chelsea Paulo,1 Laura Mitchell,1 Jennifer AH Bell,2 Seline Ta...
Abstract Background Adolescent and young adults (AYA)...
PURPOSE OF THE RESEARCH: Despite decision-making featuring throughout the trajectory of cancer care,...
Background: Low rates of participation of adolescents and young adults (AYAs) in clinical oncology t...
To access publisher's full text version of this article click on the hyperlink at the bottom of the ...
Purpose Few studies have addressed the way in which families of children with cancer make treatment ...
Adolescents and young adults (AYAs) with cancer are encouraged or expected to be involved in treatme...
BACKGROUND: Various regulations and guidelines stipulate the importance of involving adolescents in ...
Purpose: Adolescents and young adults (AYAs) aged 15-39 at diagnosis have very low cancer clinical t...
PURPOSE: There is an increasing demand for researchers to provide research results to participants. ...
Background.Various regulations and guidelines stipulate the importance of involving adolescents in d...
PROBLEM IDENTIFICATION:Involvement in treatment decision making (TDM) is considered a key element of...
Despite overall improvement in survival, morbidity, and quality of life of US patients with cancer, ...
Survival among adolescents and young adults (AYAs) ages 15 to 39 with cancer has not improved to the...
Purpose: Although cancer clinical trials (CT) offer opportunities for novel treatments that may lead...
Victoria Forcina,1 Branavan Vakeesan,1 Chelsea Paulo,1 Laura Mitchell,1 Jennifer AH Bell,2 Seline Ta...
Abstract Background Adolescent and young adults (AYA)...
PURPOSE OF THE RESEARCH: Despite decision-making featuring throughout the trajectory of cancer care,...